Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in mycobacteria.
Moreira W, Ngan GJ, Low JL, Poulsen A, Chia BC, Ang MJ, Yap A, Fulwood J, Lakshmanan U, Lim J, Khoo AY, Flotow H, Hill J, Raju RM, Rubin EJ, Dick T.
Moreira W, et al. Among authors: khoo ay.
mBio. 2015 May 5;6(3):e00253-15. doi: 10.1128/mBio.00253-15.
mBio. 2015.
PMID: 25944857
Free PMC article.